<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34410026</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1939-1676</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of veterinary internal medicine</Title><ISOAbbreviation>J Vet Intern Med</ISOAbbreviation></Journal><ArticleTitle>Brain diffusion tensor imaging in dogs with degenerative myelopathy.</ArticleTitle><Pagination><StartPage>2342</StartPage><EndPage>2349</EndPage><MedlinePgn>2342-2349</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jvim.16248</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Degenerative myelopathy (DM) in dogs shares similarities with superoxide dismutase 1-associated human amyotrophic lateral sclerosis (ALS). Brain microstructural lesions are quantified using diffusion tensor imaging (DTI) in ALS patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Characterize brain neurodegenerative changes in DM-affected dogs using DTI.</AbstractText><AbstractText Label="ANIMALS" NlmCategory="METHODS">Sixteen DM-affected and 8 control dogs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective observational study. Brain DTI was performed at baseline and every 3&#xa0;months on DM-affected dogs and compared to controls. Fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity were calculated on specified regions of interest. Gait scores (0, normal to 14, tetraplegia) were assigned at each scan. Diffusion tensor imaging values in DM-affected dogs were compared to controls, gait scores, and evaluated over time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean age was 5.7&#x2009;years (SD 3.2) in controls and 9.7&#x2009;years (SD 1.4) in DM-affected dogs. In DM-affected dogs, mean baseline gait score was 4 (SD 1), and mean score change from baseline to last scan was 4.82 (SD 2.67). Nine dogs had &#x2264;3 scans; 7 had &gt;3 scans. Accounting for age, no differences in DTI indices were identified for any brain or proximal spinal cord regions between DM-affected dogs and controls (P&#x2009;&gt;&#x2009;.05). Diffusion tensor imaging values poorly correlated with gait scores (R<sup>2</sup> &#x2009;&lt;&#x2009;.2). No significant changes were identified in diffusion indices over time (P&#x2009;&gt;&#x2009;.05).</AbstractText><AbstractText Label="CONCLUSIONS AND CLINICAL IMPORTANCE" NlmCategory="CONCLUSIONS">Diffusion tensor imaging indices did not differentiate DM-affected from control dogs, detect longitudinal changes, or differentiate disease severity. Findings do not yet support brain DTI as an imaging biomarker.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Melissa J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-6643-191X</Identifier><AffiliationInfo><Affiliation>Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shomper</LastName><ForeName>Jeremy L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Baye G</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vansteenkiste</LastName><ForeName>Daniella P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bibi</LastName><ForeName>Katherine F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Stefanie H Y</ForeName><Initials>SHY</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowal</LastName><ForeName>Joseph B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coates</LastName><ForeName>Joan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Veterinary Medicine and Surgery, University of Missouri, College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>American Boxer Charitable Foundation</Agency><Country/></Grant><Grant><GrantID>2165</GrantID><Agency>American Kennel Club Canine Health Foundation</Agency><Country/></Grant><Grant><GrantID>2430</GrantID><Agency>Amyotrophic Lateral Sclerosis Association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078323">Observational Study, Veterinary</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vet Intern Med</MedlineTA><NlmUniqueID>8708660</NlmUniqueID><ISSNLinking>0891-6640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016880" MajorTopicYN="N">Anisotropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004283" MajorTopicYN="Y">Dog Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">dog</Keyword><Keyword MajorTopicYN="N">imaging biomarker</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword><Keyword MajorTopicYN="N">white matter</Keyword></KeywordList><CoiStatement>Authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>8</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34410026</ArticleId><ArticleId IdType="pmc">PMC8478048</ArticleId><ArticleId IdType="doi">10.1111/jvim.16248</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coates JR, Wininger FA. Canine degenerative myelopathy. Vet Clin Small Anim. 2010;40:929&#x2010;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">20732599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R, Holler Y, Taylor AC, et al. Canine degenerative myelopathy: a model of human amyotrophic lateral sclerosis. Fortschr Zool. 2016;119:64&#x2010;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">26432396</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Boylan K, Jeromin A, et al. ALS biomarkers for therapy development: state of the field and future directions. Muscle Nerve. 2016;53:169&#x2010;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718795</ArticleId><ArticleId IdType="pubmed">26574709</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates JR, Mazur C, Swayze E, et al. Antisense oligonucleotide therapy targeting SOD1 for the treatment of canine degenerative myelopathy: a disease model of ALS. 2018 Proc of 29th International Symposium on ALS/MND. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(suppl 1):147. 10.1080/21678421.2018.1510208</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1510208</ArticleId></ArticleIdList></Reference><Reference><Citation>Grieve SM, Menon P, Korgaonka MS, et al. Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:85&#x2010;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">26458122</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakata K, Heishima K, Sakai H, et al. Plasma microRNA miR&#x2010;26b as a potential diagnostic biomarker of degenerative myelopathy in Pembroke Welsh Corgis. BMC Vet Res. 2019;15:192. 10.1186/s12917-019-1944-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-019-1944-3</ArticleId><ArticleId IdType="pmc">PMC6558770</ArticleId><ArticleId IdType="pubmed">31182094</ArticleId></ArticleIdList></Reference><Reference><Citation>Panek WK, Gruen ME, Murdoch DM, et al. Plasma neurofilament light chain as a translational biomarker or aging and neurodegeneration in dogs. Mol Neurobiol. 2020;57:3143&#x2010;3149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529326</ArticleId><ArticleId IdType="pubmed">32472519</ArticleId></ArticleIdList></Reference><Reference><Citation>Toedebusch CM, Bachrach MD, Garcia VB, et al. Cerebrospinal fluid levels of phosphorylated neurofilament heavy as a diagnostic marker of canine degenerative myelopathy. J Vet Intern Med. 2017;31:513&#x2010;520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5354061</ArticleId><ArticleId IdType="pubmed">28186658</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates JR, Bryan J, Lunceford J, et al. Initial assessment of canine degenerative myelopathy with positron emission tomography spinal imaging. (2019), 2019 ACVIM Forum Research Report Program. J Vet Intern Med. 2019;33:2354&#x2010;2374. 10.1111/jvim/15593</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim/15593</ArticleId><ArticleId IdType="pmc">PMC6766493</ArticleId><ArticleId IdType="pubmed">32745333</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson P, Miller AD, Cheetham J, et al. In vivo detection of microstructural spinal cord lesions in dogs with degenerative myelopathy using diffusion tensor imaging. J Vet Intern Med. 2020;35:352&#x2010;362. 10.1111/jvim.16014</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.16014</ArticleId><ArticleId IdType="pmc">PMC7848345</ArticleId><ArticleId IdType="pubmed">33350517</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Melhem ER. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced imaging techniques as objective upper motor neuron markers. Ann N Y Acad Sci. 2005;1064:61&#x2010;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">16394148</ArticleId></ArticleIdList></Reference><Reference><Citation>Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994;66:259&#x2010;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1275686</ArticleId><ArticleId IdType="pubmed">8130344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito R, More S, Melhem ER. Diffusion tensor brain imaging and tractography. Neuroimaging Clin N Am. 2002;12:1&#x2010;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">11998247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Longitudinal structural changes in ALS: a three time&#x2010;point imaging study of white and gray matter degeneration. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:232&#x2010;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Danielian LE, Braun LE, Wu T. Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J Neurol Neurosurg Psychiatry. 2018;89:53&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454927</ArticleId><ArticleId IdType="pubmed">29054917</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Carlos RC, Dwamena BS, et al. Multimodal MRI as a diagnostic biomarker for amyotrohic lateral sclerosis. Ann Clin Transl Neurol. 2014;1:107&#x2010;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4212480</ArticleId><ArticleId IdType="pubmed">25356389</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata NK, Aoki S, Okabe S, et al. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology. 2008;70:528&#x2010;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">18268244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar E, Schuster C, Machts J, et al. Multistructural white matter changes underlying cognitive and behavioural impairment in ALS &#x2013; an in vivo study using DTI. PLoS One. 2014;9:e114543. 10.1371/journal.pone.0114543</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114543</ArticleId><ArticleId IdType="pmc">PMC4263750</ArticleId><ArticleId IdType="pubmed">25501028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, Muller H&#x2010;P, Del Tredici K, et al. Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation&#x2010;based biological marker. J Neurol Neurosurg Psychiatry. 2018;89:374&#x2010;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>Metawalli NS, Benatar M, Nair G, et al. Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis. Brain Res. 2010;1348:156&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">20513367</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller HP, Turner MR, Grosskreutz J, et al. A large&#x2010;scale multicenter cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2016;87:570&#x2010;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JH, Wang S, Melhem ER, et al. Linear associations between clinically assessed upper motor neuron disease and diffusion tensor imaging metrics in amyotrophic lateral sclerosis. PLoS One. 2014;9:e105753. 10.1371/journal.pone.0105753</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105753</ArticleId><ArticleId IdType="pmc">PMC4140827</ArticleId><ArticleId IdType="pubmed">25144708</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldaranov D, Khomenko A, Kobor I, et al. Longitudinal diffusion tensor imaging&#x2010;based assessment of tract alterations: an application to amyotrophic lateral sclerosis. Front Hum Neurosci. 2017;11:567. 10.3389/fnhum.2017.00567</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2017.00567</ArticleId><ArticleId IdType="pmc">PMC5723297</ArticleId><ArticleId IdType="pubmed">29259550</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RAL, Proudfoot M, Talbot K, et al. The two&#x2010;year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. Neuroimage Clin. 2018;17:953&#x2010;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752097</ArticleId><ArticleId IdType="pubmed">29321969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson JP, Koski CJ, Boyer AC, Burbank HN, Tandan R, Filippi CG. Linear longitudinal decline in fractional anisotropy in patients with amyotrophic lateral sclerosis. Clin Neuroradiol. 2009;19:129&#x2010;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">19636503</ArticleId></ArticleIdList></Reference><Reference><Citation>March PA, Coates JR, Abyad RJ, et al. Degenerative myelopathy in 18 Pembroke Welsh Corgi dogs. Vet Pathol. 2009;46:241&#x2010;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">19261635</ArticleId></ArticleIdList></Reference><Reference><Citation>Braund KG, Vandevelde M. German Shepherd Dog myelopathy &#x2013; a morphologic and morphometric study. Am J Vet Res. 1978;39:1309&#x2010;1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">697138</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston PEJ, Barrie JA, McCulloch MC, et al. Central nervous system pathology in 25 dogs with chronic degenerative radiculomyelopathy. Vet Rec. 2000;146:629&#x2010;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">10872782</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths IR, Duncan ID. Chronic degenerative radiculomyelopathy in the dog. J Small Anim Pract. 1975;16:461&#x2010;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">1195675</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, Middleton DM, Chen S, et al. Quantitative DTI metrics in a canine model of Krabbe disease: comparisons versus age&#x2010;matched controls across multiple ages. Neuroradiol J. 2018;31:1&#x2010;9. 10.1177/1971400917733431</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1971400917733431</ArticleId><ArticleId IdType="pmc">PMC5882059</ArticleId><ArticleId IdType="pubmed">29350082</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton DM, Li JY, Chen SD, et al. Diffusion tensor imaging findings suggestive of white matter alterations in a canine model of mucopolysaccharidosis type I. Neuroradiol J. 2018;31:90&#x2010;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5789994</ArticleId><ArticleId IdType="pubmed">28695759</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell JA, Landman BA, Jones CK, et al. Effects of SNR on the accuracy and reproducibility of DTI&#x2010;derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T. J Magn Reson Imaging. 2007;26:756&#x2010;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862967</ArticleId><ArticleId IdType="pubmed">17729339</ArticleId></ArticleIdList></Reference><Reference><Citation>Polders DL, Leemans A, Hendrikse J, Donahue MJ, Luijten PR, Hoogduin JM. Signal to noise ratio and uncertainty in diffusion tensor imaging at 1.5, 3.0, and 7.0 tesla. J Magn Reson Imaging. 2011;33:1456&#x2010;1463.</Citation><ArticleIdList><ArticleId IdType="pubmed">21591016</ArticleId></ArticleIdList></Reference><Reference><Citation>Olby NJ, De Risio L, Munana KR, et al. Development of a functional scoring system in dogs with acute spinal cord injuries. Am J Vet Res. 2001;62:1624&#x2010;1628.</Citation><ArticleIdList><ArticleId IdType="pubmed">11592330</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci. 1997;146:139&#x2010;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">9077510</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Yagishita S, Amano N, Yamaoka K, Kamei T. Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex. Acta Neuropathol. 1997;94:294&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">9292701</ArticleId></ArticleIdList></Reference><Reference><Citation>Averill DR. Degenerative myelopathy in the aging German Shepherd Dog: clinical and pathologic findings. J Am Vet Med Assoc. 1973;162:1045&#x2010;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">4196853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng MC, Ho JT, Ho SL, et al. Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation. J Magn Res Imaging. 2008;27:8&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">18022844</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Winhammar JMC, Rowe DB, Kiernan MC. Corticomotoneuronal function in asymptomatic SOD&#x2010;1 mutation carriers. Clin Neurophysiol. 2010;121:1781&#x2010;1785.</Citation><ArticleIdList><ArticleId IdType="pubmed">20362497</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>